| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| David S Goldstein, Patti Sullivan, Courtney Holme. Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies. Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 2024-12-10. PMID:39656385. |
we measured urinary excretion rates of the sympathetic neurotransmitter norepinephrine, the hormone epinephrine, the autocrine-paracrine substance dopamine, the catecholamine precursor 3,4-dihydroxyphenylalanine (dopa), 3,4-dihydroxyphenylglycol (dhpg, the main neuronal metabolite of norepinephrine), and 3,4-dihydroxyphenylacetic acid (dopac, a major dopamine metabolite), in pd, paf, and msa groups and controls. |
2024-12-10 |
2024-12-12 |
Not clear |
| Jake Vernon-Elliot, Shruti Goradia, Rinaldo Bellomo, Yugeesh R Lankadeva, Louise M Burrell, Emily J Se. The effect of catecholamine versus non-catecholamine vasopressors on renal function and recovery in vasodilatory shock: A systematic review of preclinical and clinical studies. Shock (Augusta, Ga.). 2024-12-01. PMID:39617403. |
catecholamines have historically been used as the first-line vasopressors for vasodilatory shock; however, they may adversely affect renal function and recovery.objectives: to compare the effects of catecholamine and non-catecholamine vasopressors on aki risk and recovery in preclinical and clinical studies of vasodilatory shock.methods: medline, embase, and cochrane central register of controlled trials were systematically searched to identify studies reporting renal outcomes associated with catecholamine (norepinephrine, epinephrine, metaraminol, phenylephrine, dopamine) and non-catecholamine vasopressors (vasopressin, angiotensin ii), in preclinical models or adult cohorts of vasodilatory shock. |
2024-12-01 |
2024-12-06 |
Not clear |
| Fatemeh Fallah, M Reza Shishehbore, Ali Sheiban. Retraction Notice to "Fabrication of a novel sensor based on Cu quantum dot and SH-SiO2 nanoparticles supported on copper-based metal organic framework (Cu QD-SH-SiO2@Cu-MOF) and its application for the simultaneous determination of norepinephrine, piroxicam and epinephrine" [Talanta 252 (2023) 123776]. Talanta. 2024-12-01. PMID:39617651. |
retraction notice to "fabrication of a novel sensor based on cu quantum dot and sh-sio2 nanoparticles supported on copper-based metal organic framework (cu qd-sh-sio2@cu-mof) and its application for the simultaneous determination of norepinephrine, piroxicam and epinephrine" [talanta 252 (2023) 123776]. |
2024-12-01 |
2024-12-06 |
Not clear |
| Luca Marchetto, Lorenzo Zanetto, Rosanna I Comoretto, Davide Padrin, Kusum Menon, Angela Amigoni, Marco Daveri. OUTCOMES OF PEDIATRIC FLUID-REFRACTORY SEPTIC SHOCK ACCORDING TO DIFFERENT VASOACTIVE STRATEGIES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Shock (Augusta, Ga.). vol 62. issue 5. 2024-11-01. PMID:39158574. |
overall pooled mortality for patients receiving a single vasoactive was 12% (95% ci 6%-21%) of which 11% (95% ci 3%-36%) for patients receiving dopamine, 17% (95% ci 6%-37%) for epinephrine, and 7% (95% ci 1%-48%) for norepinephrine. |
2024-11-01 |
2024-11-04 |
Not clear |
| Jackeline Flores, Kenneth Nugen. Vasopressor-Inotropic Score: Review of Literature. Cardiology in review. 2024-09-10. PMID:39254546. |
the vasopressor-inotropic score provides a simple method to determine the level of support during the care of these patients; this score includes the infusion rates of norepinephrine, epinephrine, dopamine, dobutamine, and other inotropic medications. |
2024-09-10 |
2024-09-13 |
Not clear |
| Gihan Mahmoud Eldeeb, Mokhtar Ibrahim Yousef, Yasser Mohamed Helmy, Hebatallah Mohammed Aboudeya, Shimaa A Mahmoud, Maher A Kame. The protective effects of chitosan and curcumin nanoparticles against the hydroxyapatite nanoparticles-induced neurotoxicity in rats. Scientific reports. vol 14. issue 1. 2024-09-09. PMID:39251717. |
in our study, hanps significantly reduced the levels of neurotransmitters, including acetylcholine (ach), dopamine (da), serotonin (ser), epinephrine (epi), and norepinephrine (nor). |
2024-09-09 |
2024-09-13 |
rat |
| Michelle Y McGee, Ololade Ogunsina, Sadia N Boshra, Xianlong Gao, Matthias Majetscha. β-Adrenoceptor Agonists Attenuate Thrombin-Induced Impairment of Human Lung Endothelial Cell Barrier Function and Protect the Lung Vascular Barrier during Resuscitation from Hemorrhagic Shock. Biomedicines. vol 12. issue 8. 2024-08-29. PMID:39200278. |
we observed that epinephrine, norepinephrine, and phenylephrine enhanced normal and prevented tii of hulec-5a barrier function. |
2024-08-29 |
2024-09-01 |
human |
| Scott T Benken, Riya Thomas, Dustin R Fraidenburg, Jamie J Benke. Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant. Biomedicines. vol 12. issue 8. 2024-08-29. PMID:39200281. |
traditional therapies to reverse hypotension include catecholamine vasopressors (norepinephrine, epinephrine, dopamine, and phenylephrine), but their utility is limited when considering allograft complications and adverse events such as arrhythmias with agents with beta-adrenergic properties. |
2024-08-29 |
2024-09-01 |
Not clear |
| Jessie L Beebe, Cydney R Martin, Ashley F P Sanders, Jeremy Guidry, Fahad Faheem, Joel Atallah, Elliott A Beato. Short communication: catechol-O-methyltransferase allelic variation in relation to psychological and hormonal indices of stress in children and adolescents with chromosome 22q11.2 deletion syndrome (22q11.2DS). Journal of applied genetics. 2024-08-10. PMID:39126435. |
catechol-o-methyltransferase (comt) regulates epinephrine (e), norepinephrine (ne), and dopamine (da) and is implicated in both anxiety and psychotic disorders. |
2024-08-10 |
2024-08-13 |
Not clear |
| Fuwei Zhang, Ines Armando, Pedro A Jose, Chunyu Zeng, Jian Yan. G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets. Hypertension research : official journal of the Japanese Society of Hypertension. 2024-07-03. PMID:38961282. |
in organs such as the artery and kidney, hormones or neurotransmitters, such as angiotensin ii (ang ii), dopamine, epinephrine, and norepinephrine exert their functions via their receptors, with the ultimate effect of keeping normal vascular reactivity, normal body sodium, and normal blood pressure. |
2024-07-03 |
2024-07-10 |
Not clear |
| Tzu-Hao Liu, Rebecca Jen-Ling Hsieh, Hsin-Hung Chen, Tzu-Jiun Kuo, Jui-Chen Lee, Wen-Hsien L. Propranolol Alleviates Cardiac Injury After Acute Catecholamine Infusion via p38-MAPK Pathways. Journal of cardiovascular pharmacology. 2024-06-26. PMID:38922579. |
male sprague-dawley rats (n = 12) underwent a 6-hour infusion of epinephrine and norepinephrine alone, with an additional propranolol bolus (1 mg/kg) at hour 1 (n=6). |
2024-06-26 |
2024-06-29 |
rat |
| Eleni Agakidou, Ilias Chatziioannidis, Angeliki Kontou, Theodora Stathopoulou, William Chotas, Kosmas Sarafidi. An Update on Pharmacologic Management of Neonatal Hypotension: When, Why, and Which Medication. Children (Basel, Switzerland). vol 11. issue 4. 2024-04-27. PMID:38671707. |
anti-hypotensive treatment, which includes dopamine, dobutamine, epinephrine, norepinephrine, milrinone, vasopressin, terlipressin, levosimendan, and glucocorticoids, is a long-established intervention in neonates with arterial hypotension (ah). |
2024-04-27 |
2024-04-29 |
Not clear |
| Victor M Neira, Ahmed AlFaraj, Luke Wiseman, Rince John, Pantelis Andreou, Alejandro Cohe. Stability of Epinephrine, Norepinephrine, and Phenylephrine for Intravenous Infusions Stored in Three Commercial Plastic Syringe Brands. Anesthesiology. 2024-03-08. PMID:38457213. |
stability of epinephrine, norepinephrine, and phenylephrine for intravenous infusions stored in three commercial plastic syringe brands. |
2024-03-08 |
2024-03-10 |
Not clear |
| Mary Beth Bauer, Kevin P M Curri. Serotonin and the serotonin transporter in the adrenal gland. Vitamins and hormones. vol 124. 2024-02-28. PMID:38408804. |
neural crest-derived chromaffin cells in the medulla are innervated by preganglionic sympathetic neurons and secrete catecholamines (epinephrine, norepinephrine) and neuropeptides into the bloodstream, thereby functioning as the neuroendocrine arm of the sympathetic nervous system. |
2024-02-28 |
2024-03-01 |
Not clear |
| Anna T Reischl-Hajiabadi, Jürgen G Okun, Dirk Kohlmüller, Georgi Manukjan, Sebastian Hegert, Jürgen Durner, Elfriede Schuhmann, Friederike Hörster, Ulrike Mütze, Patrik Feyh, Georg F Hoffmann, Wulf Röschinger, Nils Janzen, Thomas Oplade. Newborn screening for aromatic l-amino acid decarboxylase deficiency - Strategies, results, and implication for prevalence calculations. Molecular genetics and metabolism. 2024-02-01. PMID:38302374. |
aromatic l-amino acid decarboxylase deficiency (aadcd) is a rare, autosomal-recessive neurometabolic disorder caused by variants in dopa decarboxylase (ddc) gene, resulting in a severe combined deficiency of serotonin, dopamine, norepinephrine, and epinephrine. |
2024-02-01 |
2024-02-04 |
Not clear |
| Sophia Patha. Potential Anaphylaxis to Systemic Phenylephrine: A Case Report. Hospital pharmacy. vol 59. issue 1. 2024-01-15. PMID:38223868. |
as phenylephrine is structurally similar to the endogenous catecholamines epinephrine and norepinephrine, diagnosis of her reaction was difficult. |
2024-01-15 |
2024-01-17 |
Not clear |
| Lu Jia, Pufeng Wang, Cong Li, Jianfeng Xi. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS. Shock (Augusta, Ga.). vol 60. issue 6. 2023-12-28. PMID:37548686. |
the surface under the cumulative ranking curve provided a ranking of vasoactive medications in terms of 28-day all-cause mortality from most effective to least effective: norepinephrine plus dobutamine, epinephrine, vasopressin, terlipressin, norepinephrine, norepinephrine plus vasopressin, dopamine, and dobutamine. |
2023-12-28 |
2023-12-30 |
Not clear |
| Ida Cursio, Sabrina Siliquini, Claudia Carducci, Giovanni Bisello, Mario Mastrangelo, Vincenzo Leuzzi, Mariarita Bertoldi, Carla Marin. Case report: Childhood epilepsy and borderline intellectual functioning hiding an AADC deficiency disorder associated with compound heterozygous Frontiers in neurology. vol 14. 2023-12-20. PMID:38116105. |
case report: childhood epilepsy and borderline intellectual functioning hiding an aadc deficiency disorder associated with compound heterozygous aromatic l-amino acid decarboxylase (aadc) deficiency is a rare autosomal recessive neurometabolic disorder leading to severe combined serotonin, dopamine, norepinephrine, and epinephrine deficiency. |
2023-12-20 |
2023-12-23 |
Not clear |
| Kai-Jun Tang, Yu Zhao, Xu Tao, Jing Li, Yu Chen, Darren C Holland, Tian-Yun Jin, Ao-Yun Wang, Lan Xian. Catecholamine Derivatives: Natural Occurrence, Structural Diversity, and Biological Activity. Journal of natural products. 2023-10-19. PMID:37856864. |
representative cas included the endogenous neurotransmitters epinephrine, norepinephrine, and dopamine. |
2023-10-19 |
2023-11-08 |
Not clear |
| Marcos Fernandes Gregnani, Alexandre Budu, Rogério Oliveira Batista, Fábio Henrique Ornellas, Gabriel Rufino Estrela, Adriano Cleis Arruda, Leandro Ceotto Freitas Lima, Jean Lucas Kremer, Lys Angela Favaroni Mendes, Dulce Elena Casarini, Claudimara Ferini Pacicco Lotfi, Lila Missae Oyama, Michael Bader, Ronaldo Carvalho Araúj. Kinin B1 receptor modulates glucose homeostasis and physical exercise capacity by altering adrenal catecholamine synthesis and secretion. Molecular and cellular endocrinology. 2023-10-12. PMID:37827227. |
this phenotype was related to alterations in adrenal catecholamine synthesis: increased basal epinephrine concentration and reduced norepinephrine content in response to exercise, as well decreased gene expression and protein content of tyrosine hydroxylase and decreased gene expression of dopamine beta hydroxylase and kinin b2 receptor. |
2023-10-12 |
2023-10-15 |
mouse |